Perinatal hypoxic-ischemic encephalopathy (HIE) is associated with high neonatal mortality and severe longterm neurologic morbidity. Yet the mechanisms of brain injury in infants with HIE remain largely elusive. The present study determined a novel mechanism of microRNA-210 (miR-210) in silencing endogenous neuroprotection and increasing hypoxic-ischemic brain injury in neonatal rats. The study further revealed a potential therapeutic effect of miR-210 inhibition using complementary locked nucleic acid oligonucleotides (miR-210-LNA) in 10-day-old neonatal rats in the Rice-Vannucci model. The underlying mechanisms were investigated with intracerebroventricular injection (i.c.v) of miR-210 mimic, miR-210-LNA, glucocorticoid receptor (GR) agonist and antagonist. Luciferase reporter gene assay was conducted for identification of miR-210 targeting GR 3′untranslated region. The results showed that the HI treatment significantly increased miR-210 levels in the brain, and miR-210 mimic significantly decreased GR protein abundance and exacerbated HI brain injury in the pups. MiR-210-LNA administration via i.c.v. 4 h after the HI insult significantly decreased brain miR-210 levels, increased GR protein abundance, reduced HI-induced neuronal death and brain infarct size, and improved long-term neurological function recovery. Of importance, the intranasal delivery of miR-210-LNA 4 h after the HI insult produced similar effects in decreasing HI-induced neonatal brain injury and improving neurological function later in life. Altogether, the present study provides evidence of a novel mechanism of miR-210 in a neonatal HI brain injury model, and suggests a potential therapeutic approach of miR-210 inhibition in the treatment of neonatal HIE.
Introduction
Perinatal hypoxic-ischemic encephalopathy (HIE) is associated with high neonatal mortality and severe long-term neurologic morbidity (Fernandez-Lopez et al., 2014; Li et al., 2012; Ma and Zhang, 2015; Verklan, 2009; Yager and Ashwal, 2009 ). The molecular mechanisms and the pathway of brain injury in infants with HIE remain largely elusive. Although therapeutic hypothermia is the current standard of care for newborns with moderate to severe HIE, nearly half of affected infants treated with hypothermia still die or suffer significant neurologic disability (Azzopardi et al., 2009; Higgins et al., 2011; Jacobs et al., 2011; Shankaran et al., 2005) . Thus, there is an urgent need to investigate further the underlying mechanisms and to develop additional treatment strategies.
Recently, growing evidence has revealed microRNA (miR) signatures in various neurological disorders including ischemic stroke (Moon et al., 2013) and epilepsy (Jimenez-Mateos et al., 2012) . MiRs are non-coding RNAs with about 21-22 nucleotides in length, which bind to 3′-untranslated region (3′UTR) of target mRNAs, leading to target transcript degradation and/or translational suppression (Kosik and Krichevsky, 2005; Ma and Zhang, 2015) . Many of miRs are enriched in the nervous system and play key roles in the brain developmental plasticity (Kosik, 2006) . Among them, miR-210 is The Master Hypoxamir of a specific group of miRs termed "Hypoxamirs" that are regulated by hypoxia (Chan et al., 2012) . MiR-210 has been implicated playing an important role in multiple cellular processes, including angiogenesis (Fasanaro et al., 2008 ), mitochondrial metabolism (Chan et al., 2009 and apoptotic cell death (Chio et al., 2013 ). Yet, the functional significance of miR-210 in the pathophysiology of HI-induced brain injury in the developing brain remains elusive.
Herein, we present a novel finding that miR-210 targets the 3′UTR of glucocorticoid receptor (GR) transcript and down-regulates GR protein abundance in the neonatal brain in response to the HI insult, resulting in the increased brain susceptibility to HI injury in neonatal rats. Of critical
